OSEIN does not provide investment advice, and the information contained in this memo should not be solely relied upon for making investment decisions. Investors are encouraged to conduct their own due diligence and seek professional advice before making any investment. OSEIN does not assume any liability or responsibility for investment outcomes. Additionally, AI was used to review, synthesize, and prepare the following information.
Investing in early-stage and angel investments is inherently risky, and investors should be aware that they may lose their entire investment. By proceeding with any investment, investors acknowledge and assume these risks and understand that the outcomes can be unpredictable and may not result in financial gain.
Watch DASI Simulation’s pitch session (password OSEIN)
Share your investment interest here
Website: https://dasisim.ai/
LinkedIn: linkedin.com/company/dasisimulations
CB Insights: https://app.cbinsights.com/profiles/c/RK2WV?tab=overview
PitchBook: https://pitchbook.com/profiles/company/463611-25
DASI Simulations Follow On Data Room
From Teri Sirset, CEO
“As highlighted in our Second Quarter Investor Update, we were closing in on two strategic agreements, and I am thrilled to share that we have now finalized one of them.
We have signed a Pilot Evaluation Contract with one of the world’s foremost medical device companies. This collaboration will introduce DASI's AI predictive modeling into the workflow for patient planning, evaluate their valve technology across a wide range of anatomies and case types, and demonstrate how DASI helps overcome the drawbacks of status quo analysis by improving valve selection and lifetime management. The expectation is that this agreement will lead to several new accounts being signed and activated under the partnership.
This strategic partnership is more than just a contract. It signals that the disruption has begun. Valve companies can no longer operate independently of DASI’s entry into the market. We remain valve-agnostic, and we will always be valve-agnostic. This partner recognizes the importance of that position and the value of AI, pre-procedural planning, and 4D modeling as the future of personalized patient medicine, and they are embracing that future alongside us.